Univest
Univest
  • Markets

Galaxy Surfactants Q4 FY26 Results: Announced May 14 2026 Specialty Surfactants and Personal Care Chemicals

  • May 15, 2026
  • Posted by: Neeraj Pandey
  • Category: News
No Comments

Galaxy Surfactants Q4 results were announced on May 14, 2026, at the company’s board meeting. Q4 FY26 PAT approximately Rs 76 crore on revenue approximately Rs 1,132 crore (derived: FY26 annual PAT Rs 281 crore per screener; 9M PAT approx Rs 205 crore). Q3 FY26 revenue Rs 1,334.29 crore (+27.6% YoY), PBT Rs 73.04 crore. FY26 annual revenue Rs 5,079 crore (+11% YoY). Leading specialty surfactants manufacturer supplying to FMCG personal care and home care segments globally. Investors tracking the company will find complete financial data, analysis, and FY27 outlook in this article.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Galaxy Surfactants Q4 FY26 Key Financial Highlights
  • Galaxy Surfactants Performance Analysis
  • Galaxy Surfactants FY27 Outlook
  • Frequently Asked Questions on Galaxy Surfactants Q4 FY26 Results
    • What is Galaxy Surfactants Q4 FY26 PAT?
    • When did Galaxy Surfactants announce Q4 FY26 results?
    • What is the FY27 outlook for Galaxy Surfactants?
    • Where can I track Galaxy Surfactants Q4 FY26 live data?

Galaxy Surfactants Q4 FY26 Key Financial Highlights

Metric Q4 FY26 Comparison
PAT (Net Profit) Rs 76 crore Q4 FY26 (derived from FY26 annual Rs 281 crore – 9M Rs 205 crore)
Revenue from Operations Rs 1,132 crore Q4 FY26
Ticker GALAXYSURF Sector: Specialty Surfactants and Personal Care Chemicals

Screen the best stocks on the Univest Screener.

Galaxy Surfactants Performance Analysis

The company results reflect the company’s operational performance during the January to March 2026 quarter. the company results announced May 14, 2026 with investor call on May 15. Q3 FY26 PAT was Rs 59 crore (-8.8% YoY). 9M FY26 PAT was Rs 205 crore (-10.5% YoY). FY26 9M revenue Rs 3,955 cro Investors and analysts monitoring the company results will focus on FY27 revenue guidance, margin trajectory, and management commentary on business outlook.

The company performance positions the company for FY27. Track the company analyst ratings and live stock price on the Univest Screener for real-time investment insights.

Galaxy Surfactants FY27 Outlook

Post Galaxy, investor focus for FY27 will be on revenue growth momentum, margin expansion, new order wins, and sector-specific tailwinds in the Specialty Surfactants and Personal Care Chemicals space. The Galaxy results demonstrate the company’s execution capabilities. Track Galaxy updates on the Univest Screener for analyst views and FY27 earnings estimates.

Download the Univest iOS App or the Univest Android App to track live price and Q4 FY26 earnings updates.

Frequently Asked Questions on Galaxy Surfactants Q4 FY26 Results

What is Galaxy Surfactants Q4 FY26 PAT?

Ans. Galaxy Surfactants Q4 FY26 PAT of Rs 76 crore (results declared May 14, 2026). Q4 FY26 PAT approximately Rs 76 crore on revenue approximately Rs 1,132 crore (derived: FY26 annual PAT Rs 281 crore per screener; 9M PAT approx Rs 20.

When did Galaxy Surfactants announce Q4 FY26 results?

Ans. the company results were announced on May 14, 2026, at the company’s board meeting and filed with BSE and NSE.

What is the FY27 outlook for Galaxy Surfactants?

Ans. Post the company results, investors will track FY27 guidance and growth strategies in the Specialty Surfactants and Personal Care Chemicals sector. Track live updates on the Univest Screener.

Where can I track Galaxy Surfactants Q4 FY26 live data?

Ans. Track the company live stock price, analyst ratings, and earnings updates on the Univest Screener for real-time investment data.

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Consult a SEBI-registered advisor before making any investment decision.



News Q4 Results
Author: Neeraj Pandey
Neeraj Pandey is a Financial Content Writer at Univest, covering Indian equity markets with a specialisation in quarterly earnings previews and analyst consensus analysis. His published work tracks Q4 FY26 results across 10+ sectors — from IT heavyweights like Infosys and TCS to PSUs like Coal India and Balmer Lawrie, and mid-caps like Neuland Laboratories, MCX, and Whirlpool of India. His writing approach is data-first: every article anchors on NSE/BSE filings, analyst consensus estimates (revenue, PAT, EBITDA margins), 52-week price context, and YoY/QoQ comparisons — giving retail investors the same structured framework institutional desks use before an earnings event. He combines SEO-optimised structure with rigorous data sourcing, ensuring each preview ranks for investor search intent while meeting SEBI editorial standards. All articles are reviewed by Univest's in-house equity research team, led by Ankit Jaiswal, Senior Equity Research Analyst, to meet SEBI editorial standards.

Leave a Reply Cancel reply